aMAZE Trial Continued Access Protocol

NACompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

March 9, 2020

Primary Completion Date

April 24, 2023

Study Completion Date

April 24, 2023

Conditions
Atrial Fibrillation
Interventions
DEVICE

LARIAT + PVI

LAA ligation with the LARIAT System initially performed followed by adjunctive PVI catheter ablation (RF or cryoballoon) in staged procedures

Trial Locations (25)

19010

Bryn Mawr Medical Specialists Association / Bryn Mawr Hospital, Bryn Mawr

21287

Johns Hopkins, Baltimore

30342

Emory University Hospital, Atlanta

32204

St. Vincent's HealthCare, Jacksonville

37232

Vanderbilt University, Nashville

49855

UP Health System- Marquette, Marquette

50266

Iowa Heart Center, West Des Moines

60153

Loyola University Center for Heart and Vascular Medicine, Maywood

60190

Northwestern Medicine Central DuPage Hospital, Winfield

60453

Advocate Christ Medical Center, Oak Lawn

60611

Northwestern University / Bluhm Cardiovascular Institute, Chicago

62769

Prairie Education and Research Cooperative, Springfield

64111

St. Luke's Hospital, Kansas City

66160

University of Kansas Medical Center Research Institute, Kansas City

66215

Kansas City Cardiac Arrhythmia Research, Overland Park

70121

Ochsner Medical Center, New Orleans

70360

Cardiovascular Institute of the South Clinical Research Corporation, Houma

77030

Baylor - St. Luke's Medical Center, Houston

78705

Texas Cardiac Arrhythmia Research Foundation, Austin

87102

New Mexico Heart Institute, Albuquerque

94143

University of California San Francisco, San Francisco

94305

Stanford University, Stanford

97504

Southern Oregon Cardiology, Medford

99204

Providence Sacred Heart Medical Center, Spokane

07450

The Valley Hospital, Ridgewood

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AtriCure, Inc.

INDUSTRY